Related Experiment Video

Updated: May 16, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function

Laya Kafami1, Ifa Etesami, Mina Felfeli

  • 1Pathobiology Department, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran; Shefa Neuroscience Research Center, Tehran, Iran. kafami@sina.tums.ac.ir

Journal of Neuroimmunology
|November 27, 2012
PubMed

Insights

Methadone treatment reduced disease severity and inflammatory cell infiltration in the spinal cord of mice with experimental autoimmune encephalomyelitis. This suggests a beneficial role for opioid receptor signaling in autoimmune neuroinflammation.

Area of Science:

  • Neuroimmunology
  • Immunology
  • Pharmacology

Background:

  • Methadone is known to modulate immune system responses.
  • Opioid receptor signaling plays a role in neuroinflammation.
  • Experimental autoimmune encephalomyelitis (EAE) is a mouse model for multiple sclerosis.

Purpose of the Study:

  • To investigate the effects of methadone on T cell responses and inflammatory cell infiltration in the spinal cord.
  • To explore the therapeutic potential of methadone in autoimmune neuroinflammation.

Main Methods:

  • Induction of experimental autoimmune encephalomyelitis (EAE) in mice using MOG(35-55) peptide.
  • Administration of methadone to EAE mice.
  • Assessment of clinical signs of EAE.
  • Quantification of inflammatory cell infiltration in the spinal cord.
  • Evaluation of T cell proliferation and cytokine production.

Main Results:

  • Methadone significantly suppressed clinical signs of EAE.
  • Methadone treatment led to a significant reduction in inflammatory cytokine levels produced by T cells.
  • Invasion of inflammatory cells into the spinal cord was significantly decreased in methadone-treated mice.
  • p<0.05 for all significant findings.

Conclusions:

  • Methadone exhibits therapeutic effects in a mouse model of autoimmune neuroinflammation.
  • Opioid receptor signaling may be beneficial in managing autoimmune neuroinflammatory conditions.
  • Methadone's immunomodulatory properties warrant further investigation for autoimmune diseases affecting the central nervous system.

More Related Videos

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...